Analysed DYNE THERAPEUTICS INC (DYN:NASDAQ) News Sources
Dyne Therapeutics Is Up 40%, but One Biotech Fund Just Disclosed Selling $14 Million Worth of Shares
19-05-2026
fool.com
Dyne Therapeutics Announces Initiation of Phase 3 FORZETTO Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD) Ahead of Planned BLA Submission for U.S. Accelerated Approval
20-05-2026
yahoo.com
Dyne Therapeutics Initiates Phase 3 Trial of Potential Duchenne Muscular Dystrophy Treatment
20-05-2026
yahoo.com
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20-05-2026
yahoo.com
A Look At Dyne Therapeutics (DYN) Valuation As Phase 3 FORZETTO Trial Marks Key Development Milestone
21-05-2026
yahoo.com
Dyne Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)
26-05-2026
yahoo.com
What is the current price of DYNE THERAPEUTICS INC (DYN:NASDAQ)?
The current price of DYNE THERAPEUTICS INC (DYN:NASDAQ) is $17.24.
DYNE THERAPEUTICS INC (DYN:NASDAQ) absolute price change since previous trading day?
The absolute price change of DYNE THERAPEUTICS INC (DYN:NASDAQ) since the previous trading day is $-1.39.
DYNE THERAPEUTICS INC (DYN:NASDAQ) percentage price change since previous trading day?
The percentage price change of DYNE THERAPEUTICS INC (DYN:NASDAQ) since the previous trading day is -7.4611%.
What is the most recent average sentiment score for DYNE THERAPEUTICS INC (DYN:NASDAQ)?
The most recent average sentiment score for DYNE THERAPEUTICS INC (DYN:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for DYNE THERAPEUTICS INC (DYN:NASDAQ)?
The most recent sentiment for DYNE THERAPEUTICS INC (DYN:NASDAQ) is .
SEC-8K** Filing Available For DYNE THERAPEUTICS INC (DYN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.